ANEUVO

ANEUVO is a platform and therapy development company dedicated to pioneering treatments for disabling diseases and conditions beyond the reach of traditional pharmaceuticals. Its non-invasive neuromodulation system, ExaStim®, has received CE Mark approval and FDA Breakthrough Device Designation for spinal cord injury. ExaStim® is currently cleared for commercial use solely in Europe and is limited to investigational use in the United States.